COMMUNIQUÉS West-GlobeNewswire

-
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
29/04/2024 -
Verspeeten Family Cancer Centre Unveiling Marks a Historic Milestone in Cancer Research and Treatment
29/04/2024 -
Smart For Life to Attend National Pet Food Forum on April 29 to May 2
29/04/2024 -
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
29/04/2024 -
TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting
29/04/2024 -
Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
29/04/2024 -
Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates
29/04/2024 -
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate
29/04/2024 -
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
29/04/2024 -
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
29/04/2024 -
Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement
29/04/2024 -
PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President
29/04/2024 -
Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery
29/04/2024 -
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
29/04/2024 -
Bitterroot Bio Announces Dosing of First Participants in a Phase 1, First-in-Human Study of BRB-002 in Healthy Volunteers
29/04/2024 -
Immodulon to Participate in the Wells Fargo Virtual Private Biotech Symposium
29/04/2024 -
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
29/04/2024 -
LifeMD Appoints Dr. Calum MacRae to its Board of Directors
29/04/2024 -
Scorpius Holdings Provides 2023 Year-End Business Update; Reports 570% Sequential Increase in Revenue for the Fourth Quarter of 2023
29/04/2024
Pages